The fact that significant associations were observed for biochemical enteropathy markers but not for the anthropometric indicators in this study (with the exception of the WAZ–leptin association) suggests that EE may impact later metabolic outcomes via mechanisms that operate independently of nutritional status and for which growth is a marker, rather than a mediator. The gene discussed is LEP; the disease is Abnormal intestine morphology.